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This thesis is concerned with the design and preparation
of certain organic compounds which are expected to have medicinal

properties. A discussion will be given whic:h has essentially a
two-fold purpose.

TI1e first is to discuss somewhat briefly the

currently accepted method of

~rug

design,and the second to show

to what extent thfs method has been followed in the design of

the compounds prepared.
In the design of potential drugs there is in some measure
a system which the designer should follow.

This system, known

as the method of variation, enables the designer to reduce to a
minimun the degree of randomness or chance tn searching for new
medicinals. The usefulness of this method has increased through
the years as scientific knowledge f n general and the knowledge
of medicinal chemistry and pharmacology in particular has increased.
We must acknowledge, however, that untf 1 the fundamental chemica1
phenomena proceeding in living things,and the mode of drug
action are fully understood, this method wf 11 not attain to that
perfection which is desired.

TI1e method of variation consists first in the selection of
a compound which is known through previous investigation to elicit
a certain response.

TI1is prototype as it wf 11 be referred to, may

or may not: be a clinically useful

drug~

or

I~

may be a molecular

group which is a portion of a molecule known to have medicinal
properties.
Once the prototype has been selected the designer shoull
familiarize himself with the compound. He should seek to know:
tt(l) the nature of the chief chemical classes to which the product

3
belongs. as determfned by the maf n stem nuclei or hydrocarbon
skeleton from whfch ft derives its' name; (2) the nature and number
of various functional groups that may be present, their positions,
and the proximities of such groups with respect to one another;
(3) the various possible degrees of rotation and extension of the

structure tnto various spacial configurations; (4) the lf kelfhood
of steric hindrance between various portions of the molecule

in different configurations in space; (5) the likelihood of
electronfc interactions between various portions of the molecule
including such matters as inductive and mesomerf c effects.
hyperconjugatfon, ionizabf lity, polarity, the presence of regions
of relatively high or low electron density. the possf bf Uty of

chelation, zwf tterion formation, etc.

The designer should

~hen

begin to consider the afore mentioned attributes in the 1iGht of
the substance's known pharmacological properties.

A knowledge

of the structures and pharmacologfc effects, of other substances
. having essentially the same- or even remotely similar, sites or
types of action as the prototype wi 11 also be fnvaluable." 1
After the designer has familiarized hfmse1f with the properties
of tho prototype, he then proceeds
prototype.

to

make variations on the

The methods of approach and the variations to be

made are actually peculiar to each situtation and no clear cut rules
can be laid out which must be followed exactly by every designer
of drugs.

Rather it ts important at this point to discuss

orientations of approach in drug design.

Tilis approach may involve

any one or more of three general main streams of thought, the
method of fsosterfe replacement, the method of conjunction aad
the method of disjunction.

Again, there are actually no clear cut

lines of demarcation between these three methods, but by such
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classification df scussfon of drUg des~gn is facilitated.
Langmuir2defined isosteric molecules as molecules having
the same nunber and arrangement of electrons.

Based upon similar

considerations the concept was extended by Huckel and Grimn to
certain chemical groups.

It was found that chemical groups having

the same number and arrangement of electrons show great similarities
in physical and chemical properties.

Examples of some of these

isosteres are given below:
(1) N and CO
2

(2) N20 and

co2

(3) CH2=CO and CH =N2
2

(4) organic compounds which possess one

or the other of the isosterfc pairs below
and which are otherwise identical, ·

exhibit strikingly simf 1ar physical properties:
a) -N= and -CH=

b) -0-, -NH-

and

-CH2-

c) F-. HO-, NH2- and Cff -

3

d) Ne, IE, H20 and Nff3
Tilus in designing drugs the method of f sosterfc replacement
Involves substituting tsosteres into the prototype.

In doing this

the properties of the molecule are modified so as to enhance or
diminish the desfrab1e medicinal properties of the molecule, but
not radically. frequently. however, in practfce, while employing
the general approach of isosteric replacement, workers substitute
groups which do not fulfill the definition of isostere as set

forth by Huck.el and Grimn. F.or example, they may substitute a
cyctohexyl group for a phenyl group,or even a naphthyt group for
a methyl group. Obviously, in such cases the term f sostere loses
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s
its meaning, but the approach is stf 11 good.

The greater the

deviation of the isosteres from true isosterism the greater the
expected variation in medfciaal properties of the products.

Wide

variation eould lead to fnterestfng compounds having neW properties.
In this thesf s compounds have been prepared fn which large

groups of wide diversity of structure have been substituted into
the parent nucleus.

In some cases these large groups themselves

have desirable medicinal properties.

"The method of disjunction fn drug design might be considered

as the formulation of analogues of a prototype. toward structurally
simpler products which may be viewed as partial replicas of the

prototype.'' 3 This method of variation is clearly cf4.monstr:-.:..ted
by the investigations of Dodds, Cook• Robinson, and others in thef r

work on estradfo1. This compound is known to elicit certain estrogenic
responses.

It consists of a lar.ge

.an~·

relatively planar nucleus,

a phenolic hydroxyl group and the secondary alcohol g-oup.

These

investigators screened a large number of phenols, ketones, hydrocarbons,
etc. and came up with diethylsti Uiestro 1 as the main grouping
for estrogenf c activf ty.

example of the method of df sjunction is very interesting and worthy

of consfderatfon.

Consfder the structures gfven on the next page.

Be1rfng in mfnd that these investigators were seeking the simplfest
structure whfch possessed optimum estrogenfc activities, they

proceeded to <lisjoin or open the rings 8°and C, t') substitute
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aromatic rtngs for saturated cyclic rings and decreased the size
of the hydrocarbon portions of the molecule.

AJJ of this f s

evidenced fn structures II, Ill, and IV. At this point it was
observed that the estrogenic activity progressively decreased in

compounds II, Ill, and IV. Their next course of action was,
however, not to reform rings 8 and C, but to prepare,,c,.,/3-df-

alkyt derivatives of stilbestradiot.

By plotting activity

versus

structure they found that maximum activity was reached in dfethylstilbestrfol (VI).

It Is fnterestfng to note that the

distance of separation of the hydroxyl groups in diethylstilbestriot
is the same as in estradiol. This distance, 14.S ~' is apparently
the optimum distance for estrogenfc activity.
0

o)r

14.5 A

"Drug design through conjunction is defined as the systematic
formulation of analogues of a prototype, in general, toward
structurally more complex products, which may be viewed as structures

embodying. in a general or specific way. certain or alt of the
features of the prototype. 114 An example of this method. given
below, involves an approach which might be termed the principle

of mfxed mofettes. A mof ety is regarded as a molecular grouping
which elicits a certain response. Frequently ft is desirable
to design a compound which has the medfcina1 properties possessed by
t..:>

or more individual moieties.

by uniting in a
are desired.

very specific way

Such a compound would be prepared
the moieties whose properties

7

•f'uture success f n the use of the principle of mixed moieties
depends

fundament~lly

on how successfully pharmacologists

and medicinal chemists wf 1.1 .be able to pin down. in a relatively
certain fashion. various individual moieties that activate given
molecular-level processes. Thus the primary problem at present
is rather like t.he problem that faced organic: chemistry when
it first became endowed with the concept of specifically characterizable functional groups. As such groups became more firmly
established as a basis for classifying the reactions of organic
compounds, the possibilities of predicting the character of
compounds embodying two or more such groups became more and
more feasible. An analogous type of development in the field
of medicinal chemistry involves formalization in a specific
way

of the much more complex individual pharmacophoric

m&ieties, and this 'lr40u1d presumably lead to the possibility
of predicting, with a fair degree o1 certainty, the effects
of drugs embodying two or more mof etf es. 116
The example of this method involves the preparation of a

c:omPound which has effective action ctn postganglionic
parasympathetic neuroeffector cells and also is a ganglionic
blocking agent. Host ganglionic blocking agents are bisquaternary salts, and it seems that fn the most effective
ganglionic blocking agents the nitrogen atonis are separated
by the same distance as f n hexamethoniun.

Now, while compounds

producing ganglionic blockade are effective in towering the
blood pressure in hypertension. they also have their

undesir~b1e

side effects. for instance,, decreased intestinal tone leading
to constipation.7 °Since these undesirable effects are the
result of a lack of a significant degree of specificity for

8

sympathetfc ganglia in comparison wf th parasympathetfc ganglia,
one way of increasing paresympathetfc tone

wfthout~decreasfng

ganglionic blocking actfvfty on the sympathetic side must be
sought.

Fortunately, the requirements for effective action

on postganglfonfc parasympathetic neuroeffector cells are largely
fndependent of the requirements for ganglf onfc blockade.
example,

acetyt-~-methylcholine

For

ts an effective postganglfonfc

parasympathetic stfnailant f n doses whfch effect no sugnf ffcant
a1teration fn ganglionic function, while hexamethonium has
only a slight action at postganglf onfc parasympthetfc endings
in doses that produce a high de9ree of ganglionic blockade.

The mof ety requirements for pastgangtf onf c parasympathetic
stimulant action (muscarinfc mofety) are sunmarfzed as
shown below, referred for convenience to the structure of
·acetyl cho l i ne •.
. CH/

3

g

CH

+~~)CH3

'o" 2---cH:
tH
'"Z
3

AcetylchoJine
(CH3

>3-n± CH2-CHz-CH2-Cff2-CH2 -CH2!t1-(CH3 >3
Hexamethonf um

''The above genera1fzatf on of the muscarfnfc moiety when

reviewed fn relation to the bisquaternary type of structure
fn hexamethonium, suggests the fo11owfng design, embodying both
the gang1f onfc active moiety and the muscarinfc moiety.

Muscarfnf c Moiety
(CH } -tf!c"2-CH -0-g-CH2-cH2 -f"Cctt )
2
3 3
3 3

Ganglionic Active Hofety
"Actual synthesf s and test of this product reveals it to
be, unfortunately, both a muscarfnfc stimulant and a ginglianfc
stimulant.

A close hanolgue,

9

(C2Hs)3!N-CH2-CH2-0-g-CH2-CH2-N!(C2Hs)3
however, is a produvt havfng desired type of mixed actf on.
It is both a ganglionfc blocking agent and a weak muscarinfc
stf mu1 ant. u8
Since the compounds prepared fnthe present papesr :are al I
dertvatives of (J-aminoethy1pf perazine this compound wit 1 be

considered the prototype and a discussion of fts chemical and
stereochemical propertfes wf 11 be given.

It should be pointed

out however, that frequently large groups have been attached
to fi-amfnoethy1pfperazfne, and that these large groups mfght

just as well be considered the prototype. Therefore, following

the dfscussfon of

~-amfnoethylpfperazfne

there wf11 be a

somewhat briefer discussion on each of the compounds prepared.

The followfng is the structure for ,6-aminoethylpfperazfne:

N112-C"2-CH2-0
It fs easily seen that thfs compound contafns both fnsfde and
outside the ring, the

2

-M-C~-CH -tr.:.

and its isosterfc analogue

groupfng.

(-O-CH -ctt -N~

2

2

This grouping

) are frequently fn

many different types of pharmacEutical agents, for example,

local anesthetics such as procaine.

adrenergfc blocking agents such as pfperoxan,

parasympathomimctic agents such as acetylcholfne.
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antispasmodf cs such as adiphenine,

and antf hfstaminic.agents such as diphenhydramine,

and trf pe1ennamine.

Most of the more active antihistaminf c agents contain this groupf ng.9
Chtorpheni.namine fs an interesting example of a powerful antfhfstcmfne

drug in which the fsostfc moiety ts -c-ctt2 -ctt -t~ •

2

T~is evidence

alone is very strfkfng and therefore strongly suggests that

the ~ -aminoethylpiperazfne grouping would be expected to have
favorable properties in its compounds.
Pf perazfne

itself f s relatively non-toxic and ts now used

fn the form:·of its cftrate astthe agent of choice fn the

treatment of pfnworm fnfestation.11 8
The nature of drug action fs:by no means fully understood.

There fs sane evidence, however, that drugs combine with
reception by coutanbfc forces at some stage during their actions

and most receptors are proteins. The polypeptide nature of
proteins fs welt understood, the bonding being explained in terms
of the linking together of amino acids through thefr a(.- emf no

and carboxpt groups. The spacing between these polypeptide
bonds f s regular and this spacing .f s known as t)te fdentfty
distance. Thfs distance is equat to 3.61
this is given below:

R.

A diagram iltustratfng

11

v

XR r,, t.
' t;" l ~""
ti I R ff

N" '

~

L

I

3.61

i

In compounds of known pharmacho1ogfca1 actfvity the
distance separating the functional groups frequently is found
to be equal to the fdentfty distance or some whole number
11111tip1e thereof.

In a given series of compounds tn which all

features are the same except the distances separating the
functional groups,optimum activity ts frequently observed fn
the member of the series fn which this fdentfty dfstance or some
whole number multiple thereof fs observed.

Thfs indicates that

if there is an attraction of certain groups

~n

a drug for tho

nitrogen or oxygen atoms or both in a protein, the drug becanes
more firmly attached ff the functional groups fn the dr-ug are
separated by some whole nunber multfplo of 3.61

K.1 l

"Many parasypathomirnetic (acetyl choline like) end
parasympatholytfc (chotinergic blocking) agents have a ,eparatf on

of 7.2

Rbetween the ester

aarboxyl group and the nitrogen .. This

distance is doubled between quaternary nftrogens of curaretfke

R.

The preferred ~separation of hydrogen bondfng
groups fn estrogenfc compounds is t4.5 R. 12

drugs; 14.S

Novet calculations of interatanfc dfstances info-aminoethyl-

piperazfne show that in the ethy1endfamfne moiety, planarity

of' H,e;fc,u and tack of bond strain make tho distance between
nitrogens 3.75

R.

Atso, catcu1atfons show that the distance

between nitrogens fn the pfperazfne moiety is
dist~nce

fol 1ow:

0

0

2.87 A

and the

between terminal nitrogens is 6.60 A. The calculations

12

According to Aroney and le Fevre, 13,l 4 piperfdine and
ii

,,

cyclohexane exist predominately in the chair conformation.

An

ary1 group attached to the nitrogen atom fn pfperidine lf es fn

an equatorial posttion. This apparently is due to the size
of the group.rather than to any electronic interactions with
Stated dffferentty, the aryl group Hes in the

the ring.

equational position because this position is sterically favored
over the w.xfal position. These authors also found that piperazine
exists as a mixture of the 11chair 11 and 1'boat" conformations.

The positions of the nitrogen atoms in the rings in their two
conformations are Indicated by the following diagrams:

11

Chair 11
"Boat"
Unsubstituted piperazine exists as a mixture of four structures,
three of whf ch have the cha fr conformation and one the boat,
as indicated below:

H
H

A:

·c

B

With regard to the relative abundance of each
is more 8 than A or
amount of B.

c,

D
species~

there

end D fs present in about double the

When phenyl groups are attached to the nitrogen

atoms to form 1,4-dfphenyl pfperazfne the compound consists of

a mixture of the fol lowing

two'

conformations with F predominating.

13

Ar

E

F

In order to determine the stereochemical structure of
~

-aminoethylpfperazfne, certain conclusions,based on the evidence

given above, must be made at this point.

Ff rst, ft seems

reasrinab1e that the compound must exf st as a mixture of the
chair 11 and "boat" conformatf ons wfth the latter predomfnating,

11

sf nee thf s f s the case wf th unsubstituted and disubstituted

piperazfnes.

Secondly, from steric considerations,

~he

amfnoethyl group most probably assumes an equatorial posftfon,
even though &<:cording to Aroney and LeFevre the 1,4-dfmethylpfperazfne has a small amount of the axial ~chafr"form fn the mixture.

The axial methyl dfrfvative is not nearly as sterically hindered
as would be the case with the ethylenedfamine wf th a large group

,,

attached in the ,8-posftf on.

In conclusion, the p -amfnoethylpiperazfne grouping in
the compounds prepared in this thesis is to be regarded
as consfsting of a mixture of the chair and boat forms.with the

f.5-aminoethyl group attached in equatorial positions as indicated
below.

..--.

It remains to determf ne the distances separating the nitrogen

atoms, ie., the shortest df stances from 1 to 2, from 2, tti'3, •nd
from 1 to ].

14
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A diagram of

-amf noethy1pfperazfne fs given belows

The C-N and C-C bond distances are J.47

Aand

1.54

X,

respectfvely.

15A 6
The NCC and CNC bond angles in the ring are tetrahedral! 109.5C? The

CNC bond angles outside the ring are 10s<?

Since the pfperazine ring f s symnetrical. a straight line
COMecting N and N• must pass through the center of plane ABCD.
Therefore• the distance NO, whcrre 0 f s the center of the plane.
must equal half the distance separating the nitrogen atoms f n the

ring.

In determining NO, NE and EO must be known. NE is given by

the fol lowing equation:
cos L NAE = (l;0> 2+ (A£>?:. (NE)
2(NA)(AE)
cos

0

.

2

2

2

109.5 · = (1.47) + (0.77) - (NE)

2

2{ i .. 47)(0.77)

2
2
(NE) : (1.47) +

. NE

{0.77) 2~ eos

70.s°(2)( 1.47)(0.77}

= l.87 l

*Aroney and Lef'evre assume angle CNC to be tetrahedral in their
'WOrk on pf perazf ne.
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Since lines AC and BD

The length of EO is determined as fo1Jows1

are parallel, line AB= EF, both being perpendicular to the same
lines. A lfne drawn perpendicular from AB to N bisects

Since

ANB

=109.5,
0

AND.

ANJ = si+.1sa.
sin

54.8°

=AJ

NA

= AJ

CT7

AJ

Since AJ

=(.817)(1.47) =1.20

=EO• EO is also

1.20 ft.
2
2
(No) 2 = (NE) - (Eo)

Tilerefore,

J(1.87) 2 -

.NO

=

NO

= 1.437 ft

(1.20)

2

The distance of separation of the nitrogen atoms in piperazine is,,

therefore, 2(1.437)

=2.87 ft

Tile df stance between the

nitrogen

atoms

in the ethylenediiJrnine.

portion of the molecule. will now be determined.
Since the carbon and nitrogen atoms are all considered to lfe
In the same plane fn the ethylenedf amfne portion, and thf s portion
is also symnetrfcaJ, the distance NO' is equal to half the NN••
distance. Therefore,
cosLHIO•

2

= (NI) + (10 1 )

2

-

(NO•)

2

2(NI)(IO•)
cos 109.5°= (J.47)
N0 1=1.87
NN 11 =

2

(0.771 2

- (N0)
2( 1.47)(0.77)

R

3.74 ~

+

2
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It remains now to determine angle H11 NN'.

This angle wf11 be

the sum of angles N• 1 NI, INJ, and JNN•. Angle INJ is determined
as fo11owsi

Angles IND and INA are 108°.

f'or the sake of more

convenient calculations. rather than determining angle INJ directly,
its• supplement wf 11 be determined which is angle HNJ, where angles
HNB and HNA are the supplements of angles INB and INA, and equal to

7t'

(180-tOa°).

angle

Angle INJ wi 11 then simply be the supplement of

HNJ.

By dropping lines from

ff

to points K and L on the plane NAB

where line HL is perpendicular to the plane and HK is perpendicular
to line NA. angle HliJ can be determined as follows:

In the right

triangle HNK, Jfne HH is equal to the nitrogen-carbon bond distance,
since in this case line NH is formed by rotating line NI.

Therefore:

cos LHNA::: NK
NH
cos 72

=NK

1.47

=(l.47)(.309)
NK = .454 A
NK

0

Since angle AHB is bisected by NJ. angle ANJ is equal to -!Ct09.s°),
or t;4.7tf', and since HK is perpendicular

to

NA, KL is also perpen-

dicular to NA. Therefore:
cos LANJ

= NK
NL

cos

54.75

=.454
NL

NL= .454

.577

NL

= .786 ft
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NL is also the base of triangle HNL, therefore,
cos

L.HNJ

= NL =.786 :

LHNJ
.

.

.

.

.

0

.535

t.47

NH

=57.3°0

Angle INJ is therefore (180-S].J ) = 122.7
In triangle NJO, line JO fs equal
HO is t.437
is

1.

to

i(t.54) or .77

X, and 1fne

Since triangle JNA is a right triangle,and angle ANJ

S4.1f: and line

NA is

t.47 ft, it follows that:

cos LANJ =NJ
HA

cos

54.75
NJ

=NJ

1.47

= ( .577)( t .47) = .848

0

A

Therefore:
cos

L

JNO

= (NJ) 2+ (NOl 2-

2(NJ) NO)

(JO)

2

2
2
={.848)2(2+.8f.1·437!
- (.77)
)(1. 37)

=.899
. L JNH 1 =LJNO

= 26°

Since in triangle INO•, the lines N0 1 , NI and IO• are 1.87,

1.47 and .77 R respectively, it follows
.

cos L

that:
2

2
INO• = (NO•) ~ (NI1 2- (IO•)
2(N0 1 ) NI)

=0.87) 2+ (J.47)2-

(,V)

2

2(1.87)( I .47) .

L

INH''=LIN0 1
0

=.923
=22.7°

Therefore., angle N• •NN 1 :is 171.4 which ts the sun of angles N• •NI,

lNJ, and JRN•.
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1be distance separating the terminal nitrogen atoms in

~

-amino-

ethylpiperazine, (N• •N•), is determined below:
cos

L N 11 N 1

cos

171.4°

::

2
2
2
(N• •N) + (NN•) -iN' 1 N 1 )
2(N 11 N)(NN 1

=().74) 2+ (2.87) 2-{N

11

N1 ) 2

2(3.74)(2.87)

'

N• 1 N1

= 6.60

0

A

'Dlis distance is a little short of double the identity distance

{7.2 >l).
In proteins there is hydrogen bonding between adjacent chains
17
of polypeptides as indicated below:

tt }l

'g/

c

'~/

~

J;II

,N......_
. . . ._
c...
tf R

~ ..... ,c..,.

~

ff ......

HR

H~

c/

'c . . . .

r(
H

0

'

i

I
I

HI
'ifN
~
'
'
/
'g
.
.
.
.
.
.
.
,;
~

H

It shou1d be pointed out that ff medicinals combine with protein
receptors in part through hydrogen bonding in a similar manner,
then the distance separating the hydrogen atoms attached to the

functional groups is also of some concern.

In open chain medicinals

and polypeptides the hydrogen atoms are, as indicated above, separated
by the same distance as the functional groups.

In

aminoethy1-

piperazfne, however, the hydrogen atoms attached to N• and N••
are not exactly perpendfcuJar to line N••N•, but rather are inclined at angles approximating 100°, as shm-"~ below:

!

I

The distance separating the hydrogen atoms is. therefore. somewhat
0

greater than 6.60 A. The hydrogen atom at N1 is here considered as axial.

I_

19

TI1ere are many compounds having medfcf nal properties
which contain the,8 -aminoethypiperazfne moiety or some grouping

very close

to

it. Several of these compounds will now be

ment tonerl.

(1) The following series of compounds are known to be
effective as vasodi1ators and adrenergfc blocking agents. 18
(A)

@,~) -N-CH2-CH2-Q-R
C2H5.

R:: -CH3

.

Q

.

=-t:-CHl
= -C6HS

=-Csff4N

:: -H

R :: '."CH)

= -Cfii-C6HS
0
= -C-CH3

I

R =·-C6H5

= -CH3

:: -C6H5

In a11 of these compounds the maximum activity was

obtained when w=2 as represented in the formula below

R-:-{CH2ln-~-R

?{2)

The compound 1,4-df(2-pyrazy1 )pi perazf ne was prepared

as a potential anticonvulsant and is a very active analgesic.1 9

(3)

Prochlorperazine is an excel lent antiemetic in man
,

and has been of value in mild neurotic disturbances.
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(4)
sedat1on of psychoneurotic individuals and for treatment of
tension. anxiety, insomnia, and senile excitation.21

It might be

well to point out that, as mentioned
previously,
-0- and -NH.
,_
'
are isosteric groups and, compounds containing either of them
and which are otherwise fdentic:a1 are expected to possess.
-sf mi tar

properties.

Cl~-fH· ~-CH2-Cil:!-O -CH2-Clf2-0H
(5)

©

The compound,

l-[N, N-dimethyl-n-(6-cyano-6,6-dipheny1-

hexy~ium)ethane-2-(N-m'ethy1morpho1ino)

dichloride, has been

used with good results in the treatment of hypertension.

11

The

spacial receptor protecting effect of the large groups may be

so overpow9ring that the strongly polar properties of the quaternary nitrogen atom can be abandoned in favor of tertiary
amino groups. This is seen in many typical antispasnodfcs
whcf h cause only

a barely detectable parasympathetic ganglionic -

blockade." 22

®·
-

-(CH2)5-~lffi-CH2t~

@
-..

(

CH3

I

·~

•2C1-

-..../

- (6)

The compound• 1-lfl-{dimethylamino)ethyfl -4-phenylptperazine,

is a very eff~ctfve antihfstamfne. 23

21

CH3~~2-C11z-~-~
(7) Lfnadryl is an effective antfbistamfne. 24

~(2J~~O-CH2-Cffi-~
(

\.

_,
I

Therefore, wt th regard to the prototype, " -amf noethyl -

piperazfne, it might be stated by way of stmmary thats

(I) the

compound contains the ..X-CH2-CH2-N grouping which is present in
a wide variety of medfcina1s; local anesthetics, adrenergic
blocking agents, parasympathomimetic agents, antf spas:modics and
nearly a11 of the- antibistanines; (2) the distance of the terminal

nitrogen atoms is close to twice the identity dfstanc.eJ (3) 'there

are a number of compounds i1avlng a wide variety of medicinal
properties whiti::h contain a grouping close to,if not identical to,
-aminoethylpiperazine; (4) pfperazine is a relatively non-toxic

substance. An additional fact of significance which has not
been mentioned previously is that fn many
!'s~

antispasmodics-t,:~ps

as pyrrolidine 1 pipertdine and ptperazine behave as anchoring

groups. 25
Rarely is a qrug found which has only one action on the
organism as a wb:>le. For instance# antihistamines exhibit fn

some degree the properties of the 1oca1 anesthetics, sympatholytfc
agents, antispasmodics, sympathomimetfc agents, analgesics and
anticholinergics.26 This indicates that the mode of drug action
for alt these types of compounds is probably similar.

Therefore,

when a compound is designated as an analgesic, antib'istamine,
anticholinergic:, etc., this probably mea:ts that the groups attached
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to the main stem nuclei enhance f ts 1

properties as an analgesic,

antihistamine, anticholinergic, etc.
The derivatives of /3 -aminoethylpiperazine can be expected•

therefore, to have medicinal properties, and the mode of drug
action can be expected to be the same as 111 the analgesics,

antihistanines, anticho1inergics, etc.
A brief discussion will now be given un each compound prepared

tn. this thesis.

In some cases large groups which themselves

have certain specifically characterizable pbannaculogica1 properties
have been added

to the 13-aminoethylpiperazine nucleus.

In those

instances the prepared compounds should be viewed as having

properties characteristic of all their moieties.

In most cases

the propertfes of these groups added to the parent compound are

hanmnious with the properties expected of P. -aminoethylpiperazine.
In other cases where the properties of the groups added to the
parent molecule are less specific:a11y characterizable,, the

products should be regarded as having the same properties expected
of 13-arninoethylpiperazfne with relatively mild varfatfons.

The

compounds prepared in this study are given below and are assigned
Arabic: minerals.

The compounds from the literature are indicated

by capf ta1 letters.

(1)

~ff~~-Clfi-~-cH3

1-[P-(Cyclohexylmethylamfno)ethyt]-4-methylpiperazine

This compound can be regarded as the product resulting from
the replacement of compound (l)-(A) on page 1<J. and, therefore.is

expected to have properties as a vasodilator and an adrenergic
blocking agent.
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(2)

Due to the close structural simi tari ties of camphot~ and

norcamphor, the following two compounds are discussed together
and are expected to have nearly the same properties.

1- [,e-[J,7,7-trimethyl-2-(bfcycJo ~.2.i] heptyl)amh~

·

ethy!J-4-methylpiperazf ne

Cf)-NH-Cllz-CHz-0
1- l_i3-[2-(Bfcycfo[2.2. I] heptyt)amfno]ethy!J piperazf ne
Camphor has many interesting pharmacological properties.
27
.
f s an anaJeptic. it is used as a circulatory and respiratory

stfmu1ant~8and

locally as a mild antiseptic, analgesic and

It

antipyretic~9

Compounds containing the 1-phenyl-2-aminoethane moiety are
regarded as sympathomfmetic amines and are classified broadly as

ana1eptics~ 0 In view of the fact that this structure resembles

~-CH2-cH2-NH2
amfnoethylpiperazine in certain features and

~hat

compounds of this

structure and camphor are both analeptfcs, the camphor derivative
of P., -aminoethylpfperazine is expected to have analeptic properties.

One of the undesirabJe properties of camphor is its' water fnsolubilfty and, consequently, attempts have been made to prepare water
so hi ble derfvatlves11 The camphor derivative of f.3-aminoethylpiper~ine

has Increased water solubility over camphor.

24
4)

1-[P-(MethyJ-1,2,3,4-tetrahtdro-o<.-naphthylamfno
ethyU-4-methylpiperazine

5)

@j-CHz-CHz-0
1...[p-( J,2,3,4-Tetrahydro- o(-naphthy1amf no)ethyf]
pf perazine

The followfng compound has been prepared as an antfhistamtne.
8)

1,4-Bts(2-methyl-1,4-benzodfoxane)pfperazfne
It ts a property of the benzodioxanc antf hf stamine drugs to cause
adrenergtc blockade.

This compound also has considerable central
nervous ·system depressing propertfes.32It can easily be seen that
in this compound the oxygen and nitrogen atoms are separated by

t1llO

carbon atoms as in most antfnf stamfnes and that thfs compound con, tains the pfperazine ring. Also, the groups -CH2- and -0-, ft wf 11
be recalled, are isosteres. The tetrahydronaphthyl derivatives of

,B-aminoetbylpiperazine and the benzodioxane derivative of pfperazine
all contain the flat planar benzene ring attached to a non-flat,
non-planar rfng.

This indf cates that the two compounds, (4} and

(S), will have antfhistamfnic properties.
Hethy1atfon of the amf no groups of a compound tends to decrease

toxicity~ but also tends to decrease actlvf ty.33

25

1-[p -(Dicyclopropy1methy1amino)ethyj]piperazine

7)

[> -f H-NH-CH2°CH2-QH

©
1-[.P'-(o(-Cyc1opropylbenzy1amino)ethy[)piperazine
8)

[>-cH-NH-CH2-C"2-0H
CH3
·
1- (p-(o'-.-Cyclopropy1ethyt amino)ethyl]pf perazi ne

Few compounds related to the above structures have been prepared

in which cyclopropane is used in place of a straight chain hydro-

carbon. Therefore, although these compounds are expected to have
properties as vasodilators and adrenergfc blocking agents similar
to those of the derivatives of ,8-amnfoethylpiperazine mentioned on
I

page 19. a prediction of any property modifications is not possible.
The following two compounds are similar fn some features to the above

compounds, but the analogy is not too good.

C)

~~j'\~-O-CH2-cH2-N-(C2H5 l2
/3 -Di ethy 1ami noethy l-1-benzoy 1eye1opropa:1ecarboxt1 ate

This compound is an antispasmodic and contains the -O-CH2-ctt -N
2
34~groupfng characteristic of the antihistamines. It also contains
a phenyl and a cyclopropyl group as in compound (7).

D)

@-D-N112
2-Phenylcyelopropylamine

26
Compound (D) has been used as a mood e1evatf ng drug.35
It can be seen that this compound c1ose1y resembles

the~

-

cyclopropy1benzy1amino moiety In compound (7).

An additional fact of interest ts that, cyc1opropane is
well known as an anesthetic of low toxicity and high therapeutic
f ndex.36

fH3

9)

.Qt:~2-CH2Qi-CH3
1- 1]9-(Acety1cyc1ohexy1amino)ethy(]-4-acety1
piperazine

10)

~H3
Q
.
©
=O
C"'2- -Ctf2-CH2-

R

-C-CH3

1-[,B-(Acetylbenzylandno ethyt]-4-acetylpiperazine
These compounds are also expected to possess priperties as
vasodilators and adrenergic blocking agents. but again, it is difficult
to assess the property modifications resulting from acetyJation
of the nitrogen atoms. Some compounds containing the grouping,
RCONR2, have anticonvu1sant properties.37

11)

(CH3)2-C=CH-CH2-CH2-~~~H-CH2-~ff-C"2-CH2-~H
1- [ tl-(3,7-Dimethy1-2,6-octadieny1amf no)ethy1]piperazf ne

Citrat, (CH3)2C=CHCH2CH2C(CH3)=CHCHO, is known to possess
antf-inflarrmatory. antia11ergic, antispasmodic and analgesic
propertfes.3B,39
uAccording to the modern mediator theory, pain arises as a result
of the chemical mediators histamine and acetylcholine.

Solutions

of cf tra1 possess antihistamine and antichoHnergic activity. 1he
double bond in the 6-7 position does not play an important role in
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antihistaminic activity. 1lle aldehyde group is not essentf ai for
antihistaminic activity.

Thus the atcohot, geranio1, is just as

effective as the aldehyde., citrat.

The antihistaminfc activity of

citrat and its• derivatives is not produced by a certafn.molecular
group, but is a property of the molecule as a whole, wherein considerable changes in structure may be made without greatly affecting
the activity. 40 Citra1 also reduces blood pressure in concentrations ·
of

hloo,ooo.'+1
The same properties are thus possessed by citral as those

expected of

/>

-amfnoethyJpiperazine and the union of these two moieties

should give a compound having antfhfstamfnic, anttchotinergic, and
vasodilator properties.
Although this thesfs fs not concerned wf th drugs of possible
use in the treatment of cancer, ft is interesting that citrat has
42
inhibitory action on tumors (sarcomata) in mice, and it liquefies
spontaneous tumors (carcinoma of the mammary gland) in mice.
Citral is non-toxic to normal cells in doses which cause regression
in malignant

tumo~s. 43
H3C,pH3

12)

O

~H

(\

CH=Cll-tH~NH..CHz-Cffi-~

CH3

t-fp-[}-(2,6,6-Trfmethy1-2-cyc1ohexyl)-1-methy12-propenylamino]ethyij.pfperazfne
o(-Ionone is a substance of very low toxicity. When injected
· into an animal, 2 g./kg. body weight, it is e1eminated through the
44
lungs without accident. In clinical tests, tf-ionone, also of tow
toxicity, had neurotropic, antisympathfcomimetic. and antispasmodic
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H C CH

3 '' 3

E)

CH)

~~CH-C=O
f1-lonone

activity.45,B-Ionone also has high antfcholfnergic activity.461n
very dilute solutions, 6 x 10-6 to 6 x 10-7, it reduces the activity
of hfstamfne by SO - 70% in sections of guinea pig fntestine.47

Little work has been done on the pharmacology of o<.-ionone

however, but, due to the close structural stmt1arittes, the properties of o<- tonone are at least somewhat predictable from the
properties of .61-fonone.
o(

If this 1s true, then the properties of

-lonone are harmonf us wf th those expected of P' -ami noethyl -

piperazine.

13)

~H3

ONH-CH2-CH2-0
H3c' CH3
1- LP-(2-Isopropy1-5-methy1cyc1ohexy1amino)
ethyl] pi perazi ne

In one experiment, menthol depressed the isolated heart
of both the frogc&iad rabbit by dilating the coronary vessels.

48

In another experiment menthol caused a fall fn blood pressure
in cats and rabbits, and it blocked the vasoconstrictive action

of nicotine when adninistered in the ratio of 1 part menthol to
2 parts nicottne.491n still another experiment. menthol produced
vasodtlation in the anesthetized dog.SOlhus compound (13) s~utd

have strong vasodilator properties.
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ctfa- pi- fH2
I CH3tf . CH-NH-

14)

CH2-CH-tt12

Cffi-CH2 -

0

~

1-[,8-( 3-Tropyl ami no)ethy1]pi perazi ne
1be following compounds have been prepared and were found to

have ganglionic blocking properties similar to hexamethonium.51

These compounds also reduce the blood pressurt.::.52
F)

Compound (14) is not a quaternary salt, but ft,a114?,is expected
to have vasodf lator and ganglionic blocking activity.

It wf 11 prob-

ably be less active than compounds (F).
1S}

· t- [P-(2-Hydroxy-1,2-dfphenylethytamfno)ethyl]·

·

piperazine

The foJtowing two compounds which are structurally related

to compound (1S) 1 and are used as antispasmodics.
-CH2-CH2.+ .CH3S04H~

G)

~- I

I

HJ

,_,' ricyc1amot 53
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H)

HexocycliumS4
Barger and DaJeS>reported that certain compounds containing
the moiety shown below act as vasopressors, and are termed sympathomfmetic al'lfnes. They cause a rise in blood pressure coupled with
vasoconstriction.
I)

~l:H-Cll.I(

Compound (1S) is, therefore, expected to have properties as
an antispasmocHc, and might be a vasodilator or a vasoconstrfctor.

16)

1- [p-(,B -Pyridy1methy1amfno)ethy1]ptperazfne
The following compound has been found to be an effective vaso-

df lator, and f s useful in overcoming cold-induced vascular spasm.56
J)

@

CHzOH

,

I

p -Pyrf dy1methano1
This compound can be regarded as being isosteric with the
,B-pyridylmethylamino grouping in compound (16).

Since the two

moieties fn (16) have properties as vasodltators, it is expected
that thf s compound wt 11 be a vasodl 1ator.
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The fol 1owfng preparations involve the condensation of a

primary amine. 13·aminoethylpiperazine. with aldehydes and ketones
to form Schiff bases.53 The equation for this reaction is given
below:

The Schiff base is then reduced using sodium borohydr.ide (NaBH4)

to

form the secondary amine as indicated below:

EXPERIMENTAL

32
1-[p-(Cyctohexytamino)ethyi] pf perazine

ollll-~-~-o
To 64.S g. (0.5 mole) of /3-amfnoethy1piperazine dissolved
ha 100 mt. of absolute methanol was added SO g. (0.5 mole) of
cyctohexanone with shaking.

The reaction took place rapidly.

resulting mixture was allowed to stand for three days.

The

To the mixture

was added 20 g. of NaBH4 dissolved fn absolute methanol. The methanol
was evaporated and to the resulting viscous liquid was added 10 g.
of NaOH df ssolved in 50 ml. of water.
with two ISO ml. portions of ether.

The mf xture was extracted
The ether portions were combined

and the ether evaporated. The resulting 1tqufd was distilled.
Yfeldt
Calculated for

35.4 g. (33.5%), b.p. 148-ISD°@ .6am.

c12tt25N3t

titrable N,

19.90%.

Found 19.62%.

1-[S-(AcetylcycJohexylamfno)ethyi]-4-acetytpfperazfne

~~~2-~-~-g-ci;
To JS.4 g. (0.17 mole) of 1-[,8-(cyclohexylanfno)ethyj.Jpfperazfne, from above, di ssl>tved f n 75 ml. of anhydrous pyridine
was added 32 ml. (0.34 mole) of acetic anhydride wfth shaking and
cooling. The volatile material was distilled off under a vacuum
using a water evaporator.

The resulting viscous liquid was distilled.

Yields 20.1 g. (40.0%)~ b.p.228-232°@ .2nm.
Calculated for

c16tt29N3o2 : tltrable H, 4.74%. Found 5.04%.
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1-

-(Benzytamino)ethyl piperazine

To 64.S g. (O.S mole) of f3 -aminoethylpfperazine dissolved in
100 ml. of methanol was added

53.0 g.

(0.5 mole) of benzaldehyde

with shaking. The resulting mixture was allowed to stand for three
days.

To the mixture was added 20 g. of HaBH4 dissolved in 50 ml.

of methanol.

The methanol was evaporated using an evaporator.

To

the resulting viscous liquid was added 10 g. of NaOH dissolved in
a minimun amount of water.

This basic solution was extracted with

three 100 ml. portions of ether. The ether extracts were combined
and the ether evaporated. The resulting viscous liquid was distilled.
Yield:

1-

43.2 g.

(39.4%),

b~p. 14S-1S0°@

.Snm.

(Acety1benzy1amino)ethyl -4-acetylpf perazine

~H3
;-:::\_

~=o

~CHi-N-Cffa-CH2 -

0

R

-C-CH3

To 43.2 g. (0.2 mole) of 1-[,s-(benzy1amino)ethy1]piperazfne,
from above, dissolved in 75 ml. of pyridine was added 37.S ml.
(0.4) of acetic anhydride with shaking and cooling.

The volatile

material was distilled off under a vacuun using a water aspirator.
The resulting viscous liquid was distilled.

Yield:

19.9 g.

Calculated for

(J2.8%), b.p.

c1,tt25N302 :

225-230°@ .2nm.

titrable N,

4.62%. Found 5.07%.
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t-~ .[1, 7, 7-Trfmethyt-2-Cbfcyclo(g.2. j]heptyl )amfn~ethy]-pfperazfne

To a solution of 64.S g. CO.SO mole) of P -amfnoethylpfperazfne
dissolved in 100 ml. of absolute methanol was added 76 g. CO.SO mole)

of camphor dissolved fn 100 ml. of absolute methanol.

Fifty drops

of phosphorus oxychlorfde was added and the resulting mixture was
refluxed for 48 hours.
The mixture was allowed to cool to room temperature end 20 g.

of NaBH4 dissolved fn 200 mt. of absolute methanol was added fn
small portions. After hydrogen evolution had ceased the mixture
was evaporated to dryness in an evaporator. The resulting viscous

gum was cooled and 300 ml. of
solid precipitate formed.

61! HCJ

was added wfth cooling. A

The combined so1fd mass and solutf on

was extracted four times wfth 1SO ml. portions of ether.
portions were discarded.

The ether

The acidic layer was cooled and was made

basfc wfth excess solfd NaOH.

A yellow of I rose to the surface.

The cOfDbfned oil and sotutf on was extracted wfth three 150 m1.

portions of ether. The.ether was evaporated and the resulting oil
was combfned with another portion of the same oit obtained from
a precedure identical to the one above.

The combined portions of

oft were dfstf 11ed.

Yfeld: 52.0 g.
Calculated for

(18.3%}, b.p. 143-148°@ .]mm.

c16tt32N3:

tftrab1e N,

151 85%. Found 1S.64%.

35
1- ~-[1,7.7-Trimethyl-2-(bicycto[2.2. Uheptyt)amtnii]ethy] -4methylpiperazine

In a three-neck flask was placed 66.S g.(0.2S mole) of 1- [fi-Ct,
7,7-trfmethy1-2-(bicyc10[2.2.j] heptyl)amirxi} ethy~ piperaztne dissolved
in 200 mt. of absolute methanol.

A solution of

in 150 mt. of absolute methanol was prepared.

35.5 g. of methyl iodide

Half of this solution

was placed in the refrigerator and the remaining half was placed in
a separatory funnel attached to the three-neck flask. A reflux
condenser was attached to the flask and a power stirrer was included.
The methyl iodide was introduced at a slow rate fnto the solution
being stirred.

When the first portion of methyl iodide had been

added the remainder from the refrigerator was placed in the separatory

funnel and added slowly.

The time required to introduce all of the

methyl fodtde was about six hours.
to stand overnight.

The reaction mixture was allowed

The methanol was evaporated and the resulting

viscous gun was dissolved in 200 ml. of

6!! HCl.

extracted with several portions of ether.

basic wf th excess solid NaOff.

lbe acid solution was

The acid layer was made

An oil rose to the surface.

The

aixture was extracted with severa1 portions of ether1 th& ether

layers combined and evaporated and the residue was distilled.
Yieldi

9.0 g. (12.9%). b.p. 214-218° @ )Onm.

Calculated for Ctt"llN): titrable N• 15.04%. Found 14.97%..

36

1- ~- Ei-(Bfcyclo 2.2.1 hepty1}amfn2) ethyiJ piperazfne

To 27.6 g. (0.25 mole) of norcamphor dissolved in app.-oxfmately 75 ml. of absolute methanol was added 25.8 g. (0.2 mole)
of

# -aminoethylpiperazine.

The mixture was allowed to stand

for a few hours and then 6 g. of NaBH4 was added. After
the evolution of hydrogen ceased the methanol was evaporated.
To the residue was added 6!! HC1 until the solution was acidic.

The acid solution was extracted with ether

and

was then made

basic with excess solid NaOH. This basic solution was extracted
with ether. The ether extracts were combined and the ether evaporated.
The resulting residue was distilled.

Yield:

10.9s g. {24.7%),

Calculated for

c13a25N3i

titrab1e N-

18.81%. Found 18.31%.

37
1-[£-(1 1 21 3,4-Tetrahydro-o(-naphthylamino)ethyl]pfperazine

cSCTtHi-tHi-o
To a solution of 12.9 g. (0.10 mole) of fJ -aminoethylpfperazine
dissolved in 100 ml. of absolute methanol cooled to to0 c was added
14.6 g .. (O.JO mole) of 2.3 1 4-trihydronaphthone in small portions.
The resuldng mixture was allowed to reflux for 24 hours after 15

drops of phosphorus oxychtoride had been added.
Following the refluxing the mixture was cooled in fee and 3 g.
of RaBH4 dissolved in

too mt. of

absolute methanol was added.

After

the evottion of hydrogen ceased the methanol was evaporated in an

evaporator. To this mixture was added 100 ml. of
the material went into solution. The acfd
with four

too mt.

6!!

HCJ. and all

salutJon~waseextracted

portions of ether. The acid layer was made basic:

. with excess solid NaOH, and air-:oil rose to the surface.
was extracted with three 100 mt. portions of ether.

The solutfon

The ether layers

were combined and evaporated, and the residue was dfstf tJed.

Yfeld: 31.0 g. (12.0%}. b.p. 180-189° @ Jmn.
Calculated for t

H t: :
16 25 3

titrable N,

16.22%. Found 16.11%.

38
· 1-[,8-<Methyl-1,2, 3,4-tetrahydro-o<..-naphthylami no )ethyl]-4methylpi perazi ne

A mixture of 25.9 g. (0.1 mole) of 1-[,8-( 1,2,3,4-tetrahydroo(-naphthylamino)ethyl]piperazine, 19.5 g. of formaldehyde (37%)
and 12.0 g. of formic acfd (98+ %) was placed in a round bottom
flask and heated on a steam bath for three hours.
was then refluxed overnight.

The mixture

Concentrated hydrochloric acfd

(13~g.)

was added and the excess formaldehyde and formic acid were removed,
by distillation at reduced pressure.

The residue was dissolved in

water and made alkaline by the addition1of 40% NaOH.

The oil

which separated was extracted with thr:ee 50 ml. portions of ether.
The ether extracts were combined and the ether evaporated.

The

liquid residue was distilled.
Yield:

19.9 g.

Calculated for

(69.3%),

c18H

N:
29 3

b.p. 166-170°@ .6mm.
titrable N,

14.62%.

Found 14.36%.

39
t-[p-(Dfcyc1 opropy1methylamf no)ethyl]pf peraztne

To 12.4 g. (0.1) mole) of dicyclopropyl ketone dissolved in

7S ml. of toluene was added 14.6 g. (0.11 mole) of

;ta-amfnoethyl~

piperazine wfth shaking.· An addftfona1 SO· mt. of toluene was added
and the mixture was allowed to reflux with a water trap attached.
Approximately 2 ml. of water was collected overnight.

Host of the

toluene was distf lted off under reduced pressure and to the resulting

4 (approximately 7 g.)

residue was added a large excess of NaBH
dissolved in 100 mt. of methanol.

The reduction took place fn about

four hours. The resulting solutf on was made more baste by the
addition of 15 g. of NaOH dissolved in 50 ml. of H o. After cooling,
2
the soJutf on was extracted three times with 50 ml. portions of
ether.

The ether layers were combined.

The remaining water-methanol

layer was concentrated by evaporation and extracted with 50 mt.
of ether.

This ether extract was combined with the three previous

ether extracts and the ether evaporated.

The resulting lfqufd

was dfstf Hed.

Yfe1dt 3.0 g. (12.2%).
Calculated for C H N :
13 2S 3

b.p. 163-168° @ Snm.
titrable N,

18.81%. Found 18.76%.

40
1-[,s -(::i<-Cyclopropy1ethylamino)ethy1] pfperazfne

-CH
C> -CH-NH-CH
,
2 2
CH

-0

3

To 64.S g. (O.S mole) of ..B-amfnoethylpf perazf ne dfssolved f n
SO ml of methanol was added 34 g. (0.4 mole) of

meth~

cyc1opropyl

ketone wf th shaking. The mixture was then allowed to reflux for one .
week. The mixture was treated with lS g. of NaBH4 in SO m1. of methanol.
The methanol !·:as evaporated. The resulting viscous gum was dissolved
slowly with mechanical stirring and cooling fn 300 ml. of 6,?! HC1.
The resulting acid solution was extracted three times with 50 ml.
portions of ether. The ether extracts were discarded. The acid
layer was then made basic with excess solid NaOH.
the mixture was cooled fn fee.

During thfs process

An of 1 rose to the surface. This

mixture was then "'-:"'tr acted three times wf th 100 ml. portf ons of
ether.

The ether extracts were conbfned and the ether evaporated.

The resulting lfqufd was dfstflled.

Yield: 25.S g.

(32.3%), b.p.

153-158

0

@> 19.2nm.
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To )0 .. 4 g. (0.2 mole) of citral dissolved in 100 ml. of

toluene was added 25.8 g. (0.2 mole) of /3 -aminoethylpiperazine
with swirling.

Heat was evolved. The mixture was refluxed usfng a

water trap. A quantitatfve yield of water was obtained f n about
2 hours.

To the mixture was added 6 g. of NaBH4 •

observed unti 1 a sample of methanol was added.

Ho reaction was

Complete solution

took place after 50 ml. of methanol had been added f n smal 1 portions.

The mixture was left standing overnight and a solid separated out
of solutfoni

The methanol and toluene were evaporated.

The viscous

gun whfch resulted was dissolved., with cooling. in 120 ml. of

6!!

HCJ.

This acid solution was extracted with two 100 mt. portions

of ether. The ether extracts were discarded.

To the acid layer

was added excess solid RaOff wfth cooling and an oil rose to the
surface. This basic solution was extracted with two 100 ml. portions
and three 50 ml. portions of ether.

and the ether evaporated.
Ytel~s

TI1e ether extracts were combined

The resulting viscous liquid was dlsti11ed.

t0.9 9- (20 •.5%)~ b.p. 168-172°@ .tam.
Calculated for c tt N 1 tftrabte ff# 15.83%. Found JS.36%.
16 31 3
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l·[J3.-(2-Isopropy1-5-methy1cyc1ohexy1amino)ethyj] pfperazine

H~:H-Clti-CH2-~
1

CH 3
To 15.4 g. (0.1 mole) of menthone

di~solved

in SO

ml~

of abs-

olute methanol was added t2.9 g. (0.1 mole) of fi-aminoethy1piperazine
with shaking. The mixture was allowed to stand overnight.

To the

mixture was added 3 g. of NaBH4• TI-ie mixture was allowed to stand

until the evolution of hydrogen ceased. which required about li hours.
The methanol was evaporated and to the resulting viscous liquid was

added 100 ml. of water. The liquid did not dissolve completely in
the water.

This mixture

~tas

then extracted with 100 ml. of ether.

To the water layer was added 20 g. of solid NaOH. After cooling. this
basic layer was extracted with a mixture of 100 ml. of ether and 2S ml.
of butanot. The ethor-butonol layer was removed and to the baste layer
was added an additional 20 g. of solid NaOtt"

After

cooling~

this

basic layer was extracted with 100 ml. of ether. Then«> ether extracts
and the ether-butano1 extract were combined and the volatile material
was evaporated.

The residue was distilled.

Yield: 4.s4 g. (17.0%), b.p. 160-161+0 @ .o2mn.
Calculated

~or

C16H33N3:

titrab1e N,

15.71%. Found IS.23%.
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1- !e-[)-(2.6,6-Trimethy1-2-cyclohexeny1)-1-methy1-2-propenylami~
ethyl} pfperazfne

To 19.2 g. (ti.1 cute) of o<.-ionone dissolved in SO ml. of abs-

olute methanol was added 12.9 g. (0.1 mole) of ,6'-amfnoethy1pfperazfne
with shaking.

The mixture was allowed to

and then 3 g. of NaBH4 was added.

s~and

for about 3 hours

The mixture was a11owcd to stand

~

\tnti1 the evolution of hydrogen ceased. The methanol was evaporated
and 100 ml. of water was added to the residue.
completely soluble fn the water.

The residue was not

'Tilf s mixture was extracted wfth two

100 ml. portions ant'! one 50 ml. portfon of ether.

added 20 g. of solfd MaOff.

To the water layer was

The resulting mixture was coo,1ed and ex-

tracted with 75 ml. of ether.

The ether extracts were combined and

the ether evaporated. TI1e liquid residue was distilled.

Yfeldt

7.3 g. (23.9%), b.p. t80-t85°

Calculated for C19H3sff3t

titrabte N,

(/fl

.OSmm.

IS.71%. Found IS.23%.

t- [i-(2-Hydroxy-1,2-dfphenylethytamino)ethyf] pfperazine

To 21.2 g. (0.1 mole) of benzoin

hot toluene was added 12.9 g~
with shaking.

Co.1

dis~olved

mole} of

fn 100 ml. of

P -aminoethylpiperaztne

The mixture was refluxed wf th a water trap attached.

A quantitatfve yfeld of water was obtained withtn ten minutes.

ihe ref luxf ng was stopped and three 3 g. of NaBH was added. Then

4

70 ml. of methanol was added.

The addition of the methanol took

the NaBH4 into solution resulting in the evolution of hydrogeo.
following reduction, about

ti

hours, the,methano1 and toluene we~e

evaporated and the resulting.viscous gU'lf. was dissolved in 70 mJ.

-

or 6N HCl with

cooling fn

ice. The acid solution was extracted

with 100 ml. and two SOml. portions of ether.

The acid layer

was then made basic with excess solid NaOH while cooling. A
viscous gum then rose tc. the surface. The basic solution and gum
were extracted with one 100 ml. and two 50 ml. portions of ether.
The ether was evaporated and the residue distilled.

Yield;

13.0 g.

Calculated for

(40.0%); b.p. 233-237° @ .1Sr.m.

c20tt27 N o: , titrabte,:ff,
3

12.91%.

Found t2.39X.
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1- [B-(3Tropy1amino)ethyl]pfperazine

To 10 g. (0.07 mole) of tropfnone dlissolved in apporxiimately

75 ml. of absolute methanol.was added 9 g. (0.07 mole) of /3 -aminoethylpfperazine. The mixture was allow to stand overnight. To

the mixture was added 2.8 g. of NaBH and when the evolution of
4

hydrogen ceased the methanol was evaporated. The resulting viscous

gun was di sso 1ved in water and so 1i d NaOH was added untf t two
distinct layers wre formed.

An attempt was made to extract the

mixture with ether but the upper organic layer did not dissolve
to any appreciable extent in the ether. thus forming three layers.
The upper and middle layers were separated from the lower layer.
The lower layer was extracted with approximately 75m1. of ether.

This

ether layer was added to the upper and·mfddle layers. The lower
layer was treated\.with solid NaOll and the upper )ayer thus formed was

added to the ether layers already obtained. The ether was evaporated
and the resulting viscous liquid was cfsti11ed.

;.8 g.

(21 .5%},

Calculated for

c14H28M4 :

Yields

b.p. 1160-164°"

@

.1nm.

titrabte N, 22.20%. Found 22.0)%.
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t{P-~-Cyctopropylbenzylamfno)ethy[]pfperazfne

To 64.S g. (0.5 mole) of p -aminoethyl pf perazfne dissolved in

SO ml. of methanol was added 73 g. (O.S mole)

of

pheny1cyc1opropyf

ketone wtth shaking. The mixture was allowed to reflux for one
week.

Part of the methanol was evaporated and 100

was added and the toluene dfstf Jled.

ml." of

toluene

Durfng thfs dfstf11atfon

about S ml. of tt2o· was removed from the dfstf 11ed toluene~ To
the resulting mixture was added IS g. of NaBH fn absolute methanol,

4

and the methanol evaporated.
up wfth coolfn9 and stirring

The resulting vfscous gum was taken

fn

)00

ml·. of 6!! HC1.

The acid solution

was extracted three ti mes wf th SO ml. portions of ether •.· The '
ether extracts were discarded.

The acfd layer was then made basic

with excess solid NaOH and extracted three times with 100 ml.

portf ons of ether •. The ether extracts were cord>fned and the ether
evaporated.

The resultfng lfqufd was dfstf Jted.

Yield:

1s.3s g.
.

.

(15.8%), b.p.

118-182° @ .5mn.

.

Ca1cu1ated for c14H n :
23 3

titrable N, 16.20%.

Found 16.37%.
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1-C,B-(8-Pyridylmethyl amino)ethyLJpf perazine

To a solution of 38.7 g. (O.JO mole) of fo -aminoethylpfperazfne
dissolved in 25 ml. of absolute methanol was added 32.1 g. (0.30 mole)
of 3-pyrfdinecarboxa1dehyde with shaking. The mixture was allowed
to stand for 15 minutes. after which 7.6 g. (0.2 mole) of NaBH
4
in 100 ml. of methanol was added with shaking. Upon completion of
reduction the methanol was evaporated using an evaporator. Two
1ayers appeared.

To this mixture was added 200 ml • of 6!! NaOH

and the baste mixture was extracted with 250 ml. of ether. To

the ether layer was added 100 ml. of 12!! HCt and the mixture was
cooled in an ice bath. An additional 200 ml. of ether was added
and the entire upper layer was separated and discarded. To the lower
acid SC>Jution was added 6!! NaOH unti I it became strongly baste. All
the product remained in solution.

The solution was saturated with

soJfd K2co • Two layers formed and the lower layer was discarded.
3
The upper layer was dissolved in 300 ml. of ether and 200 ml. of
ethanol. A White solid came out of solution and was filtered.

The

precipitate was discarded and the filtrate was dried over soJfd
K2co •
3

The mixture was filtered and most of the ether evaporated.

The remainder of the ethanol were distilled off using the water
aspirator and the resulting viscous liquid was distilled using a
vacullll punp.

Yield:

32.0 g. (14.5%). b.p. 176-180°@ .)nm.

Calculated for

c12H

N1
20 4

titrable N, 25.43%. Found 25.5]%.
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Unsuccessful attempts were made to obtain the reduced condensation products of {!, -amfnoethy1piperazfne with the following ketones:

"
Xanthene-9..one

1,21 3,4-Tetrahydroacridone

Antbr-one

SX)'.... ./)

I

2-Chtorothioxanthone

Ftuorenone

These compounds were refluxed, in some cases for a week
with

~-aminoethylpiperazine f n

or

more,

such solvents as xylene, toluene,

methanol and butanol, but in all case» following addition of NaBH4

and standard purification procedures, no analyzable product was
obtained.
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HETiiOD OF ANALYSIS
1be compounds prepared in this thesis were analyzed by titrating
the

bas~c

nitrc:)en atoms.

The compound shown, for example,, has three

titrable nitrogen atoms.

A small sample (0.05-Q.1S g.) of each compound was weighed,

dissolved in g1acia1 acetic acid and titrated With standardized
f)erchloric acid in glacial acetic ac:fd. During the titration,, the
solution was stirred with a magnetic stirrer

~

the progress of

the titration was followed using a Seckman Glass Electrode pH meter,,
Model H-2. The end point of the titration was determined as the

point of maximlln change fn potential per milliliter increment of
tltrant added.
The method of calculation is shown below., where 8 is the nunber

of tf trable nitrogen atoms.
B X Wt. of Sample X 1000

ml. of ACid

x N of Acid =Molecular

B X 14.03 X 100

Molecular Weight = %H

•

We1ght
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SUMMARY
A series of potential pharmaceutical derivatives of p>-aminoethylpiperazine was prepared by condensing aldehydes and ketones
with the primary amino group of

~-amfnoethytpiperazine

to form the

Schiff bases. The Schiff bases were reduced to secondary amines
using sodiun borohydride.
In nearly all of the compounds prepared, the groups attached
to the ,P-aminoethylpiperazine nucleus are known to have medicinal
properties which are the same as those expected of the 15'-aminoethylpiperazfne moiety.

The compounds are expected to have one

or more of the following activities: antispasmodic, anticholinergic,
antihistamfnic, vasodilator, ganglionic blocking, analgesic, sympathomimetfc and sympatholytic.

Tite actual activities are pending the

results of pharmacological testing by the A. H. Robins Co. Inc.
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